Viewing Study NCT06535256



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06535256
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-25

Brief Title: Compare Intraperitoneal Instillation of BupivacaineDexmedetomidine Versus BupivacaineDexamethasone on Postoperative Pain After Lap Cholecystectomy
Sponsor: None
Organization: None

Study Overview

Official Title: Comparison of Intraperitoneal Instillation of Bupivacaine With Dexmedetomidine Versus Bupivacaine With Dexamethasone on Postoperative Pain After Laparoscopic Cholecystectomy
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Comparison of intraperitoneal instillation of bupivacaine with dexmedetomidine versus bupivacaine with dexamethasone on postoperative pain after laparoscopic cholecystectomy
Detailed Description: Laparoscopy has become the preferred mode for many diagnostic and operative procedures It has the advantage better cosmetic results faster recovery short post-operative hospital stays and early resumption of normal activities Post-laparoscopic pain results from stretching of the intra-abdominal cavity peritoneal inflammation and diaphragmatic irritation caused by residual carbon-dioxide in the peritoneal cavity is very annoying to the patients

Although the severity of pain after a laparoscopic procedure is less compared to laparotomy but it is acute and can lead to increased analgesic requirements and prolonged hospital stays

Several studies have evaluated post-laparoscopic pain relief methods such as intravenous analgesics analgesic patches steroids and intra-peritoneal instillation of local anaesthetics alone or with additives

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None